APA (7th ed.) Citation

Vissers, M. F. J. M., Troyer, M. D., Thijssen, E., Pereira, D. R., Heuberger, |. J. A. A. C., Groeneveld, G. J., & Huntwork‐Rodriguez, S. (2023). A leucine‐rich repeat kinase 2 (LRRK2) pathway biomarker characterization study in patients with Parkinson's disease with and without LRRK2 mutations and healthy controls. Clinical and translational science, 16(8), 1408-1420. https://doi.org/10.1111/cts.13541

Chicago Style (17th ed.) Citation

Vissers, Maurits F. J. M., Matthew D. Troyer, Eva Thijssen, Diana R. Pereira, | Jules A. A. C. Heuberger, Geert Jan Groeneveld, and Sarah Huntwork‐Rodriguez. "A Leucine‐rich Repeat Kinase 2 (LRRK2) Pathway Biomarker Characterization Study in Patients with Parkinson's Disease with and Without LRRK2 Mutations and Healthy Controls." Clinical and Translational Science 16, no. 8 (2023): 1408-1420. https://doi.org/10.1111/cts.13541.

MLA (9th ed.) Citation

Vissers, Maurits F. J. M., et al. "A Leucine‐rich Repeat Kinase 2 (LRRK2) Pathway Biomarker Characterization Study in Patients with Parkinson's Disease with and Without LRRK2 Mutations and Healthy Controls." Clinical and Translational Science, vol. 16, no. 8, 2023, pp. 1408-1420, https://doi.org/10.1111/cts.13541.